Maxveda Health Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Maxveda Health
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dheeman Kumar, Uttamchand Jain, and Manish Shah serve as directors at the Company.
- CIN/LLPIN
U24100MH2020PTC349774
- Company No.
349774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Maxveda Health?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeman Kumar  | Director | 09-Nov-2020 | Current |
| Uttamchand Jain | Director | 09-Nov-2020 | Current |
| Manish Shah | Additional Director | 15-Sep-2021 | Current |
Financial Performance of Maxveda Health.
Maxveda Health Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maxveda Health?
Unlock access to Maxveda Health's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medilife Health Sciences Private LimitedActive 14 years 2 monthsDheeman Kumar and Uttamchand Jain are mutual person
Macleon Health Sciences Private LimitedActive 6 years 10 monthsDheeman Kumar and Uttamchand Jain are mutual person
- Medirise Life Sciences Private LimitedActive 5 years 2 months
Uttamchand Jain and Manish Shah are mutual person
- Manish Pharma Private LimitedActive 13 years 9 months
Uttamchand Jain and Manish Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maxveda Health?
Maxveda Health has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxveda Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxveda Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
